Praxis Precision Medicines (PRAX) Preferred Dividend Payments (2019 - 2020)
Praxis Precision Medicines' quarterly Preferred Dividend Payments came in at $950000.0 in Q4 2020, down 44.77% year-on-year from $1.7 million in Q1 2020, and down 75.91% quarter-over-quarter from $3.9 million in Q3 2020.
Praxis Precision Medicines has reported Preferred Dividend Payments for 2 years, with the latest figure at $950000.0 in Q4 2020.
- For the quarter ending Q4 2020, Preferred Dividend Payments fell 44.77% year-over-year to $950000.0; the trailing twelve-month figure through Sep 2021 stood at $950000.0 (down 90.27% YoY), and the FY2020 full-year result was $9.0 million, up 74.0% from the prior year.
- Preferred Dividend Payments for Q4 2020 stood at $950000.0, down from $3.9 million in the prior quarter.
- The five-year high for Preferred Dividend Payments was $3.9 million in Q3 2020, with the low at $950000.0 in Q4 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | - |
| 10 | Praxis Precision Medicines | 10.11 Bn | 9.32 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 950,000.00 |
| Sep 30, 2020 | 3.94 Mn |
| Jun 30, 2020 | 2.04 Mn |
| Mar 31, 2020 | 2.06 Mn |
| Dec 31, 2019 | 1.72 Mn |
| Sep 30, 2019 | 1.27 Mn |